Integrated valve regulator simplifies oxygen therapy

By AHHB
Wednesday, 21 September, 2016


Integrated valve regulator simplifies oxygen therapy

Coregas Integrated Valve Regulator (IVR) conveniently combines cylinder, regulator, flow meter and valve in a robust, lightweight and ready-to-use package. Coregas IVR, accessing medical oxygen quicker, easier and removes the operating costs of external regulators and flow meters. Simply attach your tubing or equipment to the unit and continue caring for your patient.
Features and benefits
Regulator and flow meter are integrated into the valve


  • No regulators or flow meters required

  • Saves time with no equipment changeovers

  • All standard flow settings are provided (1-15 lpm)

  • No maintenance costs, as product is maintained by Coregas


Dual oxygen outlets

  • Users can attach tubing to the firtree outlet and/or equipment to the D.I.O.

  • Simple, versatile functionality makes it convenient to use.


Contents gauge

  • Clearly displays gas contents in real time with no need to touch the open/close valve

  • High capacity cylinder

  • Increased gas capacity of 0.639 m3 (639 litres) saves time with less cylinder changeovers

  • Potentially lower stock holdings

  • User-friendly design

  • Two ergonomic carry handles

  • Tamper proof seal provides quality assurance

  • Lightweight cylinder package makes handling easier

  • Plastic coating makes it easy to clean

  • Staff training in 6 easy steps

  • Sleek, professional appearance ensures patient confidence


Specifications

Screen Shot 2016-09-13 at 5.30.31 PM
 
 
 
 
 
 
 
 
 
 
 
Contact Coregas to find out why making them your gases specialist could be to your advantage. Coregas Pty Ltd. Phone (02) 9794 2223 or visit coregas.com.au
coregas-logo
Related Articles

GenesisCare expands with $35m Northern Beaches cancer centre

The relocated centre has expanded its services with a new radiation therapy offering and access...

In Conversation with Royal Women's Hospital CEO Sue Matthews

An hour after the final call for visitors to leave, Professor Sue Matthews — now CEO of...

Global prostate cancer rates predicted to double by 2040

The number of annual prostate cancer deaths worldwide is predicted to rise by 85% from 375,000 in...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd